Health X Platform Limited Submits Revised CA Certificate for Name Change Approval
Health X Platform Limited, formerly known as Sastasundar Ventures Limited, has submitted a revised Chartered Accountants' certificate to BSE and NSE in support of its application to change the company name. The exchanges had requested a bifurcation of revenue to verify compliance with Regulation 45 of SEBI (LODR) Regulations, 2015. The statutory auditors' certificate confirms that more than fifty percent of the company's consolidated revenue is derived from healthcare activity, which aligns with the proposed new name. The company will send the revised certificate to shareholders at the next available opportunity through the Notice of General Meeting or other specified modes under the Companies Act, 2013.

*this image is generated using AI for illustrative purposes only.
Health X Platform Limited, formerly known as sastasundar ventures , has submitted a revised Chartered Accountants' certificate to BSE Limited and National Stock Exchange of India Limited in support of its application for changing the company name from "Sastasundar Ventures Limited" to "Health X Platform Limited." The intimation was made under Regulation 30 of the SEBI (Listing of Obligations and Disclosure Requirements) Regulations, 2015, dated 24-04-2026.
Regulatory Compliance
The stock exchanges had requested the company to furnish a bifurcation of revenue in the CA certificate to affirm compliance with conditions prescribed in Regulation 45 of the SEBI (LODR) Regulations, 2015. The revised certificate, issued by J K V S & Co., Chartered Accountants, confirms that the company has not changed its name in the preceding one-year period, satisfying Regulation 45(1)(a).
Revenue Bifurcation Details
The auditors certified that more than fifty percent of the total revenue of the company, on a consolidated basis, is through the activity suggested by the new name. The detailed bifurcation of revenue for the period from 1st January, 2025 to 31st December, 2025 is as follows:
| From 1st January, 2025 to 31st December, 2025 | Amount (Rs. in lakhs) |
|---|---|
| Revenue from business activity - Healthcare Activity | 1,20,971.84 |
| Revenue from business activity - Financial Services activity | 2,160.79 |
| Total | 1,23,132.63 |
The figures for the period have been taken from the limited review financial results filed by the company with the stock exchanges. Healthcare activity revenue constitutes approximately 98.25% of the total consolidated revenue.
Shareholder Communication
The original certificate was attached to the Postal Ballot Notice dated January 7, 2026, which was sent to the stock exchanges and dispatched to shareholders on January 13, 2026. The company will send the revised CA certificate to shareholders at the next available opportunity, either through the Notice of General Meeting or such other mode as specified in the Companies Act, 2013 read with SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015.
The statutory auditors' certificate was issued on April 9, 2026, by J K V S & Co., Firm Registration No. 318086E, with Utsav Saraf as the signing partner. The company's scrip codes are 533259 at BSE and SASTASUNDR at NSE.
Historical Stock Returns for Sastasundar Ventures
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.17% | -0.39% | -3.00% | -11.51% | +4.52% | +56.55% |
How will the rebranding to Health X Platform Limited impact the company's market positioning against established healthcare technology competitors?
What strategic acquisitions or partnerships might the company pursue to further strengthen its healthcare platform capabilities?
Will the company divest its remaining 1.76% financial services business to achieve complete focus on healthcare operations?


































